A Multi-omics Framework Based on Machine Learning as a Predictor of Cognitive Impairment Progression in Early Parkinson’s Disease

Abstract Introduction Cognitive impairment (CI) is a common non-motor symptom of Parkinson's disease (PD). However, the diagnosis and prediction of CI progression in PD remain challenging. We aimed to explore a multi-omics framework based on machine learning integrating comprehensive radiomics,...

Full description

Saved in:
Bibliographic Details
Main Authors: Yang Luo, YaQin Xiang, JiaBin Liu, YuXuan Hu, JiFeng Guo
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-02-01
Series:Neurology and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s40120-025-00716-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850039438368833536
author Yang Luo
YaQin Xiang
JiaBin Liu
YuXuan Hu
JiFeng Guo
author_facet Yang Luo
YaQin Xiang
JiaBin Liu
YuXuan Hu
JiFeng Guo
author_sort Yang Luo
collection DOAJ
description Abstract Introduction Cognitive impairment (CI) is a common non-motor symptom of Parkinson's disease (PD). However, the diagnosis and prediction of CI progression in PD remain challenging. We aimed to explore a multi-omics framework based on machine learning integrating comprehensive radiomics, cerebrospinal fluid biomarkers, and genetics information to identify CI progression in early PD. Methods Patients were first diagnosed with PD without CI at baseline. According to whether CI progressed within 5 years, patients were divided into two groups: PD without CI and PD with CI. Radiomics signatures were extracted from patients’ T1-weighted MRI. We used machine learning methods to construct radiomics, hybrid, and multi-omics models in the training set and validated the models in the testing set. Result In the two groups, we found 7, 23, and 25 radiomics signatures with significant differences in the parietal, temporal, and frontal lobes, respectively. The radiomics model using the 25 signatures of the frontal lobe had an accuracy of 0.833 and an AUC (area under the curve) of 0.879 to predict CI progression. In addition, the hybrid model fused with the cerebrospinal fluid Aβ level had an accuracy of 0.867 and an AUC of 0.916. In our study, the multi-omics model showed the best predictive performance. The accuracy of the multi-omics model was 0.900, and the average AUC value after five-fold cross-validation was 0.928. Conclusion Radiomics signatures have a recognition effect in the CI progression in early PD. Multi-omics frameworks combining radiomics, cerebrospinal fluid biomarkers, and genetic information may be a potential predictor of CI progression in PD.
format Article
id doaj-art-e1647a9c6bac4554b44c4ae86e480b2a
institution DOAJ
issn 2193-8253
2193-6536
language English
publishDate 2025-02-01
publisher Adis, Springer Healthcare
record_format Article
series Neurology and Therapy
spelling doaj-art-e1647a9c6bac4554b44c4ae86e480b2a2025-08-20T02:56:20ZengAdis, Springer HealthcareNeurology and Therapy2193-82532193-65362025-02-0114264365810.1007/s40120-025-00716-yA Multi-omics Framework Based on Machine Learning as a Predictor of Cognitive Impairment Progression in Early Parkinson’s DiseaseYang Luo0YaQin Xiang1JiaBin Liu2YuXuan Hu3JiFeng Guo4Department of Neurology, XiangYa Hospital, Central South UniversityDepartment of Neurology, XiangYa Hospital, Central South UniversityDepartment of Neurology, XiangYa Hospital, Central South UniversityDepartment of Neurology, XiangYa Hospital, Central South UniversityDepartment of Neurology, XiangYa Hospital, Central South UniversityAbstract Introduction Cognitive impairment (CI) is a common non-motor symptom of Parkinson's disease (PD). However, the diagnosis and prediction of CI progression in PD remain challenging. We aimed to explore a multi-omics framework based on machine learning integrating comprehensive radiomics, cerebrospinal fluid biomarkers, and genetics information to identify CI progression in early PD. Methods Patients were first diagnosed with PD without CI at baseline. According to whether CI progressed within 5 years, patients were divided into two groups: PD without CI and PD with CI. Radiomics signatures were extracted from patients’ T1-weighted MRI. We used machine learning methods to construct radiomics, hybrid, and multi-omics models in the training set and validated the models in the testing set. Result In the two groups, we found 7, 23, and 25 radiomics signatures with significant differences in the parietal, temporal, and frontal lobes, respectively. The radiomics model using the 25 signatures of the frontal lobe had an accuracy of 0.833 and an AUC (area under the curve) of 0.879 to predict CI progression. In addition, the hybrid model fused with the cerebrospinal fluid Aβ level had an accuracy of 0.867 and an AUC of 0.916. In our study, the multi-omics model showed the best predictive performance. The accuracy of the multi-omics model was 0.900, and the average AUC value after five-fold cross-validation was 0.928. Conclusion Radiomics signatures have a recognition effect in the CI progression in early PD. Multi-omics frameworks combining radiomics, cerebrospinal fluid biomarkers, and genetic information may be a potential predictor of CI progression in PD.https://doi.org/10.1007/s40120-025-00716-yParkinson’s diseaseCognitive impairmentMachine learningMagnetic resonance imagingCerebrospinal fluidWhole genome sequencing
spellingShingle Yang Luo
YaQin Xiang
JiaBin Liu
YuXuan Hu
JiFeng Guo
A Multi-omics Framework Based on Machine Learning as a Predictor of Cognitive Impairment Progression in Early Parkinson’s Disease
Neurology and Therapy
Parkinson’s disease
Cognitive impairment
Machine learning
Magnetic resonance imaging
Cerebrospinal fluid
Whole genome sequencing
title A Multi-omics Framework Based on Machine Learning as a Predictor of Cognitive Impairment Progression in Early Parkinson’s Disease
title_full A Multi-omics Framework Based on Machine Learning as a Predictor of Cognitive Impairment Progression in Early Parkinson’s Disease
title_fullStr A Multi-omics Framework Based on Machine Learning as a Predictor of Cognitive Impairment Progression in Early Parkinson’s Disease
title_full_unstemmed A Multi-omics Framework Based on Machine Learning as a Predictor of Cognitive Impairment Progression in Early Parkinson’s Disease
title_short A Multi-omics Framework Based on Machine Learning as a Predictor of Cognitive Impairment Progression in Early Parkinson’s Disease
title_sort multi omics framework based on machine learning as a predictor of cognitive impairment progression in early parkinson s disease
topic Parkinson’s disease
Cognitive impairment
Machine learning
Magnetic resonance imaging
Cerebrospinal fluid
Whole genome sequencing
url https://doi.org/10.1007/s40120-025-00716-y
work_keys_str_mv AT yangluo amultiomicsframeworkbasedonmachinelearningasapredictorofcognitiveimpairmentprogressioninearlyparkinsonsdisease
AT yaqinxiang amultiomicsframeworkbasedonmachinelearningasapredictorofcognitiveimpairmentprogressioninearlyparkinsonsdisease
AT jiabinliu amultiomicsframeworkbasedonmachinelearningasapredictorofcognitiveimpairmentprogressioninearlyparkinsonsdisease
AT yuxuanhu amultiomicsframeworkbasedonmachinelearningasapredictorofcognitiveimpairmentprogressioninearlyparkinsonsdisease
AT jifengguo amultiomicsframeworkbasedonmachinelearningasapredictorofcognitiveimpairmentprogressioninearlyparkinsonsdisease
AT yangluo multiomicsframeworkbasedonmachinelearningasapredictorofcognitiveimpairmentprogressioninearlyparkinsonsdisease
AT yaqinxiang multiomicsframeworkbasedonmachinelearningasapredictorofcognitiveimpairmentprogressioninearlyparkinsonsdisease
AT jiabinliu multiomicsframeworkbasedonmachinelearningasapredictorofcognitiveimpairmentprogressioninearlyparkinsonsdisease
AT yuxuanhu multiomicsframeworkbasedonmachinelearningasapredictorofcognitiveimpairmentprogressioninearlyparkinsonsdisease
AT jifengguo multiomicsframeworkbasedonmachinelearningasapredictorofcognitiveimpairmentprogressioninearlyparkinsonsdisease